Form 4: SeaStar Medical Holding Corp: Executive Receives RSU Award

SeaStar Medical Holding Corp reports a restricted stock unit award granted to Chief Medical Officer Kevin Chung, with vesting scheduled over multiple dates.

Summary

• Kevin Chung, Chief Medical Officer of SeaStar Medical Holding Corp, was granted a restricted stock unit (RSU) award.
• The award consists of 7,202 shares of common stock.
• The RSUs are scheduled to vest in three equal installments on July 1, 2026, November 1, 2026, and March 1, 2027.
• Following this transaction, Kevin Chung beneficially owns 28,021 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports on routine executive compensation in the form of RSU awards and does not contain significant financial performance or strategic updates.

Positives

• Grant of restricted stock units to a key executive, indicating potential alignment of executive interests with shareholder value.
• The RSU award is structured with staggered vesting dates, encouraging long-term commitment from the Chief Medical Officer.

Future Outlook

The RSU award is subject to future vesting dates, indicating ongoing compensation tied to continued service.

Industry Context

StockSavvy.ai notes that the granting of RSUs to key executives is a common practice in the biotechnology and medical device sectors to attract and retain talent, aligning executive incentives with long-term company performance and value creation.

Stakeholder Impact

• Shareholders: The RSU award represents a form of compensation that dilutes existing share ownership slightly upon vesting, but also aims to incentivize executive performance for long-term shareholder value.

Next Steps

• Vesting of RSU installments on July 1, 2026, November 1, 2026, and March 1, 2027.

Key Dates

Keywords

Form 4, SEC Filing, SeaStar Medical Holding Corp, ICU, Restricted Stock Units, RSU, Executive Compensation, Beneficial Ownership, Kevin Chung, Vesting Schedule